Clinical significance and biological roles of CARMA3 in human bladder carcinoma

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4131-4136

  Man, Xiaojun ^a   He, Jiani ^a   Kong, Chuize ^a   Zhu, Yuyan ^a   Zhang, Zhe ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; CARMA3; Cyclin D1; Proliferation

Indexed keywords

CASPASE RECRUITMENT DOMAIN AND MEMBRANE ASSOCIATED GUANYLATE KINASE LIKE DOMAIN PROTEIN 3; CYCLIN D1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CARD10 PROTEIN, HUMAN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CCND1 PROTEIN, HUMAN;

ADULT; ARTICLE; BLADDER CANCER CELL LINE; BLADDER CARCINOMA; CANCER GRADING; CELL PROLIFERATION; CLINICAL FEATURE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; AGED; BLADDER TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; AGED; CARD SIGNALING ADAPTOR PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84902997281     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1540-2     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10-29.
2. Wahafu W, He ZS, Zhang XY, Zhang CJ, et al. The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells. Tumour Biol. 2011;32:931-9.
3. Shan GY, Zhang Z, Chen QG, Yu XY, et al. Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma. Tumour Biol. 2012;33:847-55.
4. Blonska M, Lin X. NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res. 2010;21:55-70.
5. Wang L, Guo Y, Huang WJ, Ke X, et al. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem. 2001;276:21405-9.
6. Banan A, Zhang LJ, Farhadi A, Fields JZ, et al. PKC-beta1 isoform activation is required for EGF-induced NF-kappaB inactivation and IkappaBalpha stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers. Am J Physiol Cell Physiol. 2004;286:C723-38. (Pubitemid 38292679)
7. McAllister-Lucas LM, Ruland J, Siu K, Jin X, et al. CARMA3/Bcl10/MALT1- dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci U S A. 2007;104:139-44. (Pubitemid 46067998)
8. Grabiner BC, Blonska M, Lin PC, You Y, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 2007;21:984-96. (Pubitemid 46625646)
9. Wang D, You Y, Lin PC, Xue L, et al. Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proc Natl Acad Sci U S A. 2007;104:145-50. (Pubitemid 46067999)
10. Wu GL, Yuan JL, Huang XD, Rong JF, et al. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma. Tumour Biol. 2013;34:3431-5.
11. Zhao T, Miao Z, Wang Z, Xu Y, et al. CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells. Tumour Biol. 2013;34:3041-7.
12. Miao Z, Zhao T, Wang Z, Xu Y, et al. CARMA3 is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression. Biochem Biophys Res Commun. 2012;425:781-7.
13. Li Z, Qu L, Dong Q, Huang B, et al. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One. 2012;7:e36903.
14. Li X, Liu D, Liu X, Jiang W, et al. CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-kappaB activation and NO production. Tumour Biol. 2012;33:1607-18.
15. Wang X, Deng Y, Mao Z, Ma X, et al. CCN1 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway in pancreatic cancer. Tumour Biol. 2012;33:1745-58.
16. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007;98:629-35. (Pubitemid 46563437)
17. Witzel II, Koh LF, Perkins ND. Regulation of cyclin D1 gene expression. Biochem Soc Trans. 2010;38:217-22.
18. Mahanivong C, Chen HM, Yee SW, Pan ZK, et al. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene. 2008;27:1273-80. (Pubitemid 351294695)
19. Jiang T, Grabiner B, Zhu Y, Jiang C, et al. CARMA3 is crucial for EGFR-Induced activation of NF-kappaB and tumor progression. Cancer Res. 2011;71:2183-92.